What is the difference between Levonorgestrel And Ethinyl Estradiol and Medroxyprogesterone?

Levonorgestrel And Ethinyl Estradiol and Medroxyprogesterone are both Hormones, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Levonorgestrel And Ethinyl Estradiol and Medroxyprogesterone be used for the same conditions?

Both medications are prescribed for overlapping indications including a progestin and and ethinyl estradiol. Always verify with your prescriber and the current FDA label before switching.

Is Levonorgestrel And Ethinyl Estradiol the same as Medroxyprogesterone?

No. Levonorgestrel And Ethinyl Estradiol (Levonorgestrel And Ethinyl Estradiol) and Medroxyprogesterone (Medroxyprogesterone) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Levonorgestrel And Ethinyl Estradiol or Medroxyprogesterone?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Levonorgestrel And Ethinyl Estradiol to Medroxyprogesterone?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Levonorgestrel And Ethinyl Estradiol vs Medroxyprogesterone

Compare Levonorgestrel And Ethinyl Estradiol (Hormone) and Medroxyprogesterone (Medroxyprogesterone), clinical data, side effects, and patient experiences.

Levonorgestrel And Ethinyl Estradiol

· Hormone

How it works

12.1 Mechanism of Action COCs prevent pregnancy primarily by suppressing ovulation.

Approved for

a progestin

and ethinyl estradiol

an estrogen

indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )

OralTablet

Medroxyprogesterone

Medroxyprogesterone, Provera, Depo-Provera · Hormone

How it works

Other agent

Approved for

See full prescribing information

OralTablet

Quick Comparison

Levonorgestrel And Ethinyl EstradiolMedroxyprogesterone

Drug Class

Hormone

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Pregnancy

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Levonorgestrel And Ethinyl Estradiol

Nausea

0.1-1%

Abdominal Pain

0.1-1%

Drug Not Working

0.1-1%

Headache

0.1-1%

Medroxyprogesterone

Drug Not Working

0.1-1%

Nausea

0.1-1%

Headache

0.1-1%

Depression

0.1-1%

Fatigue

0.1-1%

Anxiety

0.1-1%

Weight Gain

0.1-1%

Dizziness

0.1-1%

FDA Warnings

Levonorgestrel And Ethinyl Estradiol

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop if a thrombotic or thromboembolic event occurs
Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years
If feasible, stop Iclevia at least 4 weeks before and through 2 weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism
The risk of postpartum thromboembolism decreases after the third postpartum week, whereas the likelihood of ovulation increases after the third postpartum week

Medroxyprogesterone

WARNING: CARDIOVASCULAR DISORDERS, BREAST CANCER AND PROBABLE DEMENTIA FOR ESTROGEN PLUS PROGESTIN THERAPY Cardiovascular Disorders and Probable Dementia Estrogen plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia
( See CLINICAL STUDIES and WARNINGS, Cardiovascular Disorders and Probable Dementia
) The Women’s Health Initiative (WHI) estrogen plus progestin substudy reported an increased risk of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and myocardial infarction (MI) in postmenopausal women (50 to 79 years of age) during 5
( See CLINICAL STUDIES and WARNINGS, Cardiovascular Disorders

Clinical Trial Data

No head-to-head clinical studies found for Levonorgestrel And Ethinyl Estradiol vs Medroxyprogesterone.

Levonorgestrel And Ethinyl Estradiol vs Medroxyprogesterone: What You Should Know

Key Differences

Both Levonorgestrel And Ethinyl Estradiol and Medroxyprogesterone belong to the Hormone class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

Levonorgestrel And Ethinyl Estradiol carries 4 FDA warnings. Medroxyprogesterone carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Levonorgestrel And Ethinyl Estradiol vs Norgestimate And Ethinyl Estradiol→Estradiol Valerate And Estradiol Valerate vs Levonorgestrel And Ethinyl Estradiol→Desogestrel And Ethinyl Estradiol vs Levonorgestrel And Ethinyl Estradiol→Etonogestrel And Ethinyl Estradiol vs Levonorgestrel And Ethinyl Estradiol→Levonorgestrel And Ethinyl Estradiol vs Levonorgestrel And Ethinyl Estradiol Tablets→Estradiol And Progesterone vs Levonorgestrel And Ethinyl Estradiol→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Levonorgestrel And Ethinyl Estradiol: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Medroxyprogesterone: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Levonorgestrel And Ethinyl Estradiol vs Medroxyprogesterone

Compare Levonorgestrel And Ethinyl Estradiol (Hormone) and Medroxyprogesterone (Medroxyprogesterone), clinical data, side effects, and patient experiences.

Levonorgestrel And Ethinyl Estradiol

· Hormone

How it works

12.1 Mechanism of Action COCs prevent pregnancy primarily by suppressing ovulation.

Approved for

a progestin

and ethinyl estradiol

an estrogen

indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )

OralTablet

Medroxyprogesterone

Medroxyprogesterone, Provera, Depo-Provera · Hormone

How it works

Other agent

Approved for

See full prescribing information

OralTablet

Quick Comparison

Levonorgestrel And Ethinyl EstradiolMedroxyprogesterone

Drug Class

Hormone

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Pregnancy

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Levonorgestrel And Ethinyl Estradiol

Nausea

0.1-1%

Abdominal Pain

0.1-1%

Drug Not Working

0.1-1%

Headache

0.1-1%

Medroxyprogesterone

Drug Not Working

0.1-1%

Nausea

0.1-1%

Headache

0.1-1%

Depression

0.1-1%

Fatigue

0.1-1%

Anxiety

0.1-1%

Weight Gain

0.1-1%

Dizziness

0.1-1%

FDA Warnings

Levonorgestrel And Ethinyl Estradiol

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop if a thrombotic or thromboembolic event occurs
Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years
If feasible, stop Iclevia at least 4 weeks before and through 2 weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism
The risk of postpartum thromboembolism decreases after the third postpartum week, whereas the likelihood of ovulation increases after the third postpartum week

Medroxyprogesterone

WARNING: CARDIOVASCULAR DISORDERS, BREAST CANCER AND PROBABLE DEMENTIA FOR ESTROGEN PLUS PROGESTIN THERAPY Cardiovascular Disorders and Probable Dementia Estrogen plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia
( See CLINICAL STUDIES and WARNINGS, Cardiovascular Disorders and Probable Dementia
) The Women’s Health Initiative (WHI) estrogen plus progestin substudy reported an increased risk of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and myocardial infarction (MI) in postmenopausal women (50 to 79 years of age) during 5
( See CLINICAL STUDIES and WARNINGS, Cardiovascular Disorders

Clinical Trial Data

No head-to-head clinical studies found for Levonorgestrel And Ethinyl Estradiol vs Medroxyprogesterone.

Levonorgestrel And Ethinyl Estradiol vs Medroxyprogesterone: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Levonorgestrel And Ethinyl Estradiol: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Medroxyprogesterone: DailyMed label · FAERS adverse events · ClinicalTrials.gov